Bayer Group Consoli­dated State­ments of Changes in Equity

 

 

Capital stock

 

Capital reserves

 

Retained earnings incl. net income

 

Exchange differences

 

Fair-value measurement of securities

 

Cash flow hedges

 

Revaluation surplus

 

Equity attributable to Bayer AG stockholders

 

Equity attributable to non-controlling interest

 

Equity

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Dec. 31, 2015

 

2,117

 

6,167

 

16,581

 

(622)

 

24

 

(23)

 

21

 

24,265

 

1,180

 

25,445

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase

 

 

 

3,491

 

 

 

 

 

 

 

 

 

 

 

3,491

 

 

 

3,491

Dividend payments

 

 

 

 

 

(2,067)

 

 

 

 

 

 

 

 

 

(2,067)

 

(58)

 

(2,125)

Other changes

 

 

 

 

 

129

 

53

 

 

 

 

 

(4)

 

178

 

157

 

335

Other comprehensive income

 

 

 

 

 

(781)

 

614

 

57

 

45

 

 

 

(65)

 

(10)

 

(75)

Income after income taxes

 

 

 

 

 

4,531

 

 

 

 

 

 

 

 

 

4,531

 

295

 

4,826

Dec. 31, 2016

 

2,117

 

9,658

 

18,393

 

45

 

81

 

22

 

17

 

30,333

 

1,564

 

31,897

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

(2,233)

 

 

 

 

 

 

 

 

 

(2,233)

 

(131)

 

(2,364)

Other changes

 

 

 

 

 

2,727

 

 

 

 

 

 

 

(4)

 

2,723

 

(2,025)

 

698

Other comprehensive income

 

 

 

 

 

628

 

(1,915)

 

17

 

(88)

 

 

 

(1,358)

 

(106)

 

(1,464)

Income after income taxes

 

 

 

 

 

7,336

 

 

 

 

 

 

 

 

 

7,336

 

758

 

8,094

Dec. 31, 2017

 

2,117

 

9,658

 

26,851

 

(1,870)

 

98

 

(66)

 

13

 

36,801

 

60

 

36,861

Compare to Last Year